कृपया अन्य खोज का प्रयास करें
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. The company is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with relapsed and refractory leukemia and lymphoid malignancies, as well as solid tumors and non-Hodgkin lymphoma; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat advanced or metastatic solid tumors. Its product candidates also include VIP943 in Phase 1 clinical trials for the treatment of relapsed/refractory acute myeloid leukemia, myelodysplastic syndrome, and B-cell acute lymphoblastic leukemia; and VIP924 in preclinical studies for the treatment of B-cell malignancies. Vincerx Pharma, Inc. was founded in 2019 and is based in Palo Alto, California.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Laura I. Bushnell | 54 | 2020 | Independent Director |
Francisco D. Salva | 52 | 2020 | Independent Director |
Howard A. Burris | - | 2021 | Member of Scientific Advisory Board |
Brian J. Druker | 67 | 2020 | Independent Director |
John H. Lee | 55 | 2020 | Independent Director |
John C. Byrd | - | 2021 | Founder & Chairman of Scientific Advisory Board |
Anthony W. Tolcher | - | 2021 | Member of Scientific Advisory Board |
Ruth E. Stevens | 64 | 2021 | Independent Director |
Andre Goy | - | 2021 | Member of Scientific Advisory Board |
Apostolia Tsimberidou | - | 2024 | Member of Scientific Advisory Board |
Naval G. Daver | - | 2024 | Member of Scientific Advisory Board |
Ian W. Flinn | - | 2021 | Member of Scientific Advisory Board |
Alice Mims | - | 2024 | Member of Scientific Advisory Board |
Marina Konopleva | - | 2024 | Member of Scientific Advisory Board |
Uma Borate | - | 2024 | Member of Scientific Advisory Board |
Amer Zeidan | - | 2024 | Member of Scientific Advisory Board |
Raquel E. Izumi | 54 | 2020 | Co-Founder, President, COO, Secretary & Director |
Ahmed M. Hamdy | 59 | 2020 | Co-Founder, Chairman & CEO |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है